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Germ cell specification is accompanied by epi-
genetic remodeling, the scale and specificity of
which are unclear. Here, we quantitatively delineate
chromatin dynamics during induction of mouse em-
bryonic stem cells (ESCs) to epiblast-like cells
(EpiLCs) and from there into primordial germ cell-
like cells (PGCLCs), revealing large-scale reorgani-
zation of chromatin signatures including H3K27me3
and H3K9me2 patterns. EpiLCs contain abundant
bivalent gene promoters characterized by low
H3K27me3, indicating a state primed for differen-
tiation. PGCLCs initially lose H3K4me3 from many
bivalent genes but subsequently regain this mark
with concomitant upregulation of H3K27me3, partic-
ularly at developmental regulatory genes. PGCLCs
progressively lose H3K9me2, including at lamina-
associated perinuclear heterochromatin, resulting
in changes in nuclear architecture. T recruits
H3K27ac to activate BLIMP1 and early mesodermal
programs during PGCLC specification, which is
followed by BLIMP1-mediated repression of a broad
range of targets, possibly through recruitment and
spreading of H3K27me3. These findings provide a
foundation for reconstructing regulatory networks
of the germline epigenome.INTRODUCTION
Epigenetic reprogramming refers to genome-wide chromatin-
state remodeling leading to fundamental changes of cellular
phenotypes, and it has critical implications for broad areas of
medical science. The key examples include physiologic reprog-
ramming during germ cell development (Kafri et al., 1992; Monk
et al., 1987) and artificial reprogramming in induced pluripotency
(Takahashi and Yamanaka, 2006) or somatic cell nuclear transfer
into oocytes (Gurdon, 1962). While the mechanism for the latter
examples is inherently difficult to analyze due to the low effi-
ciency and high stochasticity, the mechanism for the former
should be amenable to precise genetic/biochemical analysis
as a deterministic activity imposed by a program for germ cell
specification (Saitou et al., 2012). Furthermore, and importantly,
impaired epigenetic reprogramming in germ cells leads to a
variety of critical defects, including loss of germ cells, impaired
development of embryos, and impaired development/physi-
ology of offspring. Thus, it is essential in reproductive biology/
medicine to understand epigenetic regulation and its conse-
quences during germ cell development.
The germ cell lineage in mice arises as primordial germ cells
(PGCs) at around embryonic day (E) 7.25 (Ginsburg et al.,
1990; Saitou et al., 2002). PGCs repress a somatic mesodermal
program, regain a transcriptional network for pluripotency,
and, during their migration, initiate epigenetic reprogramming
that includes reduction of histone H3 lysine 9 di-methylation
(H3K9me2), elevation of H3K27 tri-methylation (H3K27me3),
and demethylation of 5-methylcytosine (5mC) (SeisenbergerCell Stem Cell 16, 517–532, May 7, 2015 ª2015 Elsevier Inc. 517
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Figure 1. Transcriptional Foundation for In Vitro PGC Specification
(A) Scheme for in vitro PGC specification. BV, Blimp1-mVenus; SC, Stella-ECFP. Bar, 50 mm.
(B) The log2 expression level-frequency plots for the expression of genes with high, intermediate, and low CpG promoters (HCP, ICP, and LCP, respectively).
Dotted lines indicate a log2 expression level of 8, which corresponds to the expression of 20 copies of genes per cell (Kurimoto et al., 2006).
(legend continued on next page)
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et al., 2012; Seki et al., 2005). Consequently, by E13.5 in embry-
onic gonads, PGCs acquire a unique epigenetic state with an
extremely low level of genome-wide 5mC (Seisenberger et al.,
2012). Thus, in reprogramming PGCs, DNA methylation and
transcription are largely uncoupled and a mechanism indepen-
dent of DNA methylation, most likely, that by histone modifi-
cations promotes transcriptional control (Seisenberger et al.,
2012). Subsequently, male and female germ cells establish
unique epigenomes for the spermatogenic and oogenic path-
ways, respectively. Although recent advances in sequencing
technologies have uncovered consequences of epigenetic
reprogramming—particularly the genome-wide distribution of
5mC—during germ cell development (Lee et al., 2014), there is
a lack of information as to how PGCs establish their epige-
nome—particularly the genome-wide histone modification
states—at the outset and what the overall mechanism of
epigenetic reprogramming by germ cells might be. This has
mainly been because PGCs are specified in small numbers
(40) and are intractable to quantitative analysis, and because
there is no appropriate in vitro system that recapitulates germ
cell development.
Recent studies have shown that embryonic stem cells (ESCs)/
induced pluripotent stem cells (iPSCs) are induced into epiblast-
like cells (EpiLCs), and EpiLCs are in turn induced into PGC-like
cells (PGCLCs) with capacity for both spermatogenesis and
oogenesis (Hayashi et al., 2011, 2012). The global gene-expres-
sion dynamics during PGCLC induction are highly similar to
those for PGC specification and development until around
E9.5, and PGCLCs appear to acquire epigenetic properties
similar to those of PGCs at around E9.5 (Hayashi et al., 2011),
demonstrating that the in vitro PGC specification is a proper
reconstitution of the in vivo pathway and provides an appropriate
model for analysis of the mechanisms underlying PGC specifi-
cation and development. Here, using this system, we investigate
the chromatin-state reprogramming, and in particular, the
histone modification reprogramming, for PGC specification
and development.
RESULTS
Global Transcription Regulation
We first performed a systematic evaluation of transcriptomes of
four key cell types (ESCs, EpiLCs, day 2 [d2] PGCLCs, and d6
PGCLCs) during in vitro PGC specification (Figure 1A) (Hayashi
et al., 2011; Nakaki et al., 2013). We classified the 17,050 genes
into those bearing high (10,848), intermediate (2,438), and low
(3,764) CpG density promoters (HCP, ICP, and LCP, respec-
tively) (Weber et al., 2007). The HCP genes include house-
keeping genes and developmental regulators, whereas the
LCP genes include highly tissue-specific genes. All four cell
types predominantly expressed the HCP genes (Figure 1B), indi-(C) Gene expression changes. The numbers of genes upregulated (>2 fold, marke
a neighboring cell type are indicated. The numbers of genes expressed at the hi
(D) GO analysis of genes expressed at the highest levels in the four cell types.
(E) Enrichment of genes for the indicated GO terms.
(F) ChIP-seq track transitions for H3K4me3, H3K27ac, H3K27me3, and H3K9me
See also Figure S1.cating that the HCP genes regulate key properties of the PGC
specification pathway.
We explored genes that were upregulated or downregulated
(>2-fold) between the successive stages (2.8%–5.9%) and
identified those expressed at the highest level in ESCs (774,
the ESC genes), EpiLCs (608, the EpiLC genes), d2 PGCLCs
(932, the d2 PGCLC genes), or d6 PGCLCs (1,131, the d6
PGCLC genes) (Figure 1C). The Gene Ontology (GO) function
category analysis revealed that genes for ‘‘stem cell mainte-
nance’’ are enriched in the ESC genes but are depleted in the
EpiLC genes, and then again become prevalent in the d2 and
d6 PGCLC genes (Figures 1D and 1E and Figure S1A). In
contrast, genes for ‘‘one-carbon metabolic process,’’ including
Dnmt3a, Dnmt3b, Satb1, and Suv420h1, were prevalent among
the EpiLC genes (Figures 1D and 1E and Figure S1A). Notably,
the EpiLC genes did not show overt enrichment of genes for
developmental regulators (Figures 1D and 1E), despite the fact
that EpiLCs were induced from ESCs by withdrawal of an
inhibitor of the mitogen-activated protein kinase (MAPK)
pathway (PD0325901) and stimulation by Activin A and basic
fibroblast growth factor (bFGF). Instead, the genes for develop-
mental regulators such as those for ‘‘embryonic morphogen-
esis’’ and ‘‘pattern specification process’’ were highly enriched
in the d2 PGCLC genes (Figures 1D and 1E and Figure S1A).
The ESC and d6 PGCLC genes were distinguished mainly by
their unique metabolic, signaling, and cell cycle properties (Fig-
ure 1D). For example, the ESC genes were enriched with genes
for ‘‘lipid biosynthetic process,’’ ‘‘sterol metabolic process,’’ and
‘‘oxidation reduction,’’ whereas the d6 PGCLC genes were
characterized by genes playing roles in the ‘‘cell cycle,’’ ‘‘protein
amino acid phosphorylation,’’ and ‘‘response to DNA damage
stimulus.’’ The d6 PGCLC genes were also characterized by
those for ‘‘programmed cell death,’’ including both positive
(Apc and Brca1) and negative (Akt1 and Bag3) regulators of
apoptosis, consistent with the fact that migrating PGCs are
balanced in transducing apoptotic signals and readily eliminated
by apoptosis when mis-located or depleted from survival
signals (Runyan et al., 2006). The EpiLC genes were also charac-
terized by unique metabolic properties, with genes for the
‘‘sterol biosynthetic process,’’ ‘‘lipid biosynthetic process,’’
and ‘‘glucose metabolic process’’ (Figure 1D). These analyses
provide a clear delineation of key transcriptional properties of
the four cell types during in vitro PGC specification.
Quantification of Chromatin-State Dynamics
and BLIMP1 Binding
To explore chromatin-state dynamics during in vitro PGC
specification, we developed a protocol for the representative
amplification of chromatin-immunoprecipitated (ChIP-ed) DNA
from a relatively small number of samples (Experimental Proce-
dures), as the number of PGCLCs obtained per experiment isd by corresponding colors) and unchanged (gray) in each cell type compared to
ghest level in each cell type are indicated in bold next to each cell type.
2 in the Prdm1, Dnmt3b, and T loci (50 kb).
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on the order of105. We measured the distribution of H3 (nucle-
osome), H3K4me3 (promoters), H3K27ac (acetylation) (active
enhancers), H3K27me3 (repression by polycomb complex 2
[PRC2]], and H3K9me2 (repression by G9A/GLP). For the detec-
tion of BLIMP1-binding sites, we generated a knockin mouse
strain in which the EGFP sequence is fused in-frame to the
first ATG of Blimp1, derived ESCs homozygously bearing the
EGFP-Blimp1 knockin alleles, and induced PGCLCs for
the ChIP-sequencing (ChIP-seq) analysis using an anti-GFP
antibody (Figures S1B–S1F). See Figures S2 and S3A–S3C and
Supplemental Experimental Procedures for the normalization
of the ChIP-seq data.
Figure 1F shows ChIP-seq track transitions for the histone
modifications around Prdm1, Dnmt3b, and T loci. Consistent
with their expression, while Prdm1 showed a specific
H3K4me3 peak around its promoter in d2 and d6 PGCLCs,
Dnmt3b showed such a peak in EpiLCs and T showed it in d2
PGCLCs (Figure 1F). Consistently, the three loci exhibited
several distinct H3K27ac peaks in relevant cell types, which
would represent their enhancers (Figure 1F). Indeed, one prom-
inent peak around 10 kb upstream from a transcription start site
(TSS) of Prdm1 corresponds to a T-binding site for Prdm1
upregulation in PGCLCs (Aramaki et al., 2013). On the other
hand, while the Prdm1 and T loci were deposited with a ‘‘lawn’’
of high-level H3K27me3 in ESCs and to a lesser extent in EpiLCs,
they exhibited no H3K27me3 in d2 PGCLCs: the T locus
regained H3K27me3 in d6 PGCLCs. As to the Dnmt3b locus,
the upstream region exhibited high-level H3K27me3 in ESCs
and lost it in EpiLCs, and the whole locus regained it in d6
PGCLCs (Figure 1F). Regarding H3K9me2, the three loci ex-
hibited similar modification patterns in ESCs, EpiLCs, and d2
PGCLCs, albeit at different levels, and all three loci exhibited a
significant reduction of this modification in d6 PGCLCs (Fig-
ure 1F). Thus, the histone modifications of the three key genes
provide not only a precise reflection/prediction of their active/
repressed states, but also novel information as to their regulatory
mechanism during in vitro PGC specification.
Regulation of Promoter and Enhancer Usage
We analyzed the transitions of H3K4me3 and H3K27ac during
in vitro PGC specification. In all cell types, a vast majority of
the genes with high H3K4me3 were HCP genes (Figure 2A)
and the log2 H3K4me3 levels around the TSSs were positively
correlated with the log2 gene-expression levels (Figure S4A).
Consistent with the notion that gene expression involves com-
plex and dynamic enhancer usage (Calo and Wysocka, 2013),Figure 2. Promoter and Enhancer Usage for In Vitro PGC Specification
(A) The log2 H3K4me3 level-frequency plots for the HCP, ICP, and LCP genes. D
(B) Heat map representation of the changes in gene expression, H3K4me3, and H
(1, 2) for each cell type are shown.
(C) Heat map representation of cell-type-specific H3K27ac peaks and expressio
(D) Venn diagram showing that genes (numbers indicated) with cell-type-specific
(E) ChIP-seq tracks for cell-type-specific H3K27ac peaks in the Tead4, Dnmt3b,
(F) Fraction of genes (color codes indicated) with cell-type-specific H3K27ac pe
(G) Enrichment of transcription factor (TF)-binding sites in cell-type-specific H3K
(H) Venn diagrams showing the co-existence of multiple TF-binding sites in cell-ty
gene numbers in respective categories are indicated.
See also Figures S3 and S6 and Table S5.the global changes in H3K27ac were more pronounced than
those in gene expression and in H3K4me3 (Figure 2B). We iden-
tified H3K27ac peaks (<15 kb from the TSSs and gene bodies)
specific to each cell type: many of the genes with such peaks
show specific and high-level expression in each cell type (Fig-
ure 2C). Accordingly, a vast majority of cell-type-specific peaks
were associatedwith different genes in each cell type (Figure 2D).
For example, Tead4,Dnmt3b, Fgf8, andGata2 exhibited specific
H3K27ac peaks and the highest expression in ESCs, EpiLCs, d2
PGCLCs, and d6 PGCLCs, respectively (Figures 2C and 2E).
The cell-type-specific H3K27ac peaks were associated with
6%–39% of the genes differentially expressed between adja-
cent stages, and such peaks were, with increasing threshold
levels, prevalent in genes downregulated in the ESC-to-EpiLC
transition and upregulated in the EpiLC-to-d2 PGCLC transition
(Figure 2F), suggesting a critical role of specific enhancer usage
for the maintenance of naive pluripotency and the induction of a
mesoderm program/specification of germ cell fate.
We explored whether consensus sequences for any transcrip-
tion factor (TF) binding were enriched in H3K27ac peaks specific
to each cell type, and we identified a high prevalence of such
sequences for unique, but partially overlapping, TFs for each
cell type (Figure 2G): for example, while SOX2 exhibited enrich-
ment in three cell types (ESCs, EpiLCs, and d6 PGCLCs), KLF4,
ZIC3, and TFAP2C showed specific enrichment in ESCs,
EpiLCs, and d6 PGCLCs, respectively. Reflecting highly specific
enhancer usage for the induction of a mesoderm program/
specification of germ cell fate in d2 PGCLCs (Figure 2F), the
binding sites for TFs involved in mesoderm formation were
enriched in d2 PGCLCs (Figure 2G). Importantly, a majority of
the H3K27ac peaks bear multiple TF-binding motifs (Figure 2H),
suggesting that genes specific to each cell type are regulated by
a combination of distinct yet partially overlapping sets of TFs.
We looked into the relationship between the binding sites of
OCT4, a key pluripotent factor, in ESCs and EpiLCs (Buecker
et al., 2014) and H3K27ac peaks. Notably, OCT4-binding sites
specific to ESCs exhibited substantial enrichment of H3K27ac
in ESCs and d6 PGCLCs, whereas those present in both ESCs
and EpiLCs showed enrichment of H3K27ac in all cell types
(Figure S3D). These findings indicate that OCT4 distinctively reg-
ulates a specific set of common genes in ESCs and d6 PGCLCs,
while it controls many other targets similarly in all the cell types,
highlighting a similarity between ESCs and d6 PGCLCs in the
regulatory network for pluripotency. Thus, the potential en-
hancers we have identified provide a foundation for delineating
regulatory networks orchestrating PGC specification.otted lines correspond to a log2 expression level of 8.
3K27ac levels (correlation coefficients). The values for two biological replicates
n of associated genes.
H3K27ac peaks exhibit little overlap.
Fgf8, and Gata2 loci (50 kb).
aks plotted against expression level changes.
27ac peaks in the four cell types.
pe-specific H3K27ac peaks in the four cell types. Representative genes and the
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Figure 3. Dynamics of H3K27me3 for In Vitro PGC Specification
(A) The log2 H3K27me3 IP level-frequency plots for the genome (single-copy regions, 2 kb sliding windows with 1 kb overlaps, red) and the HCP, ICP, and LCP
genes (color codes indicated). The log2 H3K27me3 IP levels corresponding to a log2 expression level of 8 are indicated by dotted lines.
(B) The H3K27me3 IP levels in repeat elements in the four cell types.
(C) ChIP-seq track transition for the H3K27me3 IP levels in the 10 Mb region around Pax5.
(legend continued on next page)
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Regulation of Polycomb Repression
We next examined the transitions of H3K27me3 during in vitro
PGC specification. Remarkably, the genome-wide IP levels of
H3K27me3 (for definition, see Supplemental Experimental Pro-
cedures) changed in a dynamic fashion during in vitro PGC spec-
ification (Figures 3A–3C and Figures S4A and S4B), a finding
demonstrating observations by immunofluorescence and west-
ern blot analysis (Seki et al., 2005): the H3K27me3 IP level was
highest throughout the genome and around the TSSs in ESCs
and decreased significantly in EpiLCs. The genome-wide
H3K27me3 reached the lowest IP level in d2 PGCLCs, which,
however, exhibited a high level of H3K27me3 specifically around
a subset of TSSs (Figures 3A and 3C and Figures S4A and S4B).
The H3K27me3 IP level recovered significantly throughout the
genome, around the TSSs, and in the gene bodies in d6 PGCLCs
(Figures 3A and 3C and Figure S4B). A vast majority of the TSSs
of the LCP genes weremarked by high-level H3K27me3 in all cell
types (Figure 3A).
The H3K27me3 IP levels around the TSSs exhibited bimodal
distributions with negative correlation to the gene expression
levels in all cell types (Figures 3A and 3C and Figure S4A), and
the log2 expression levels of 8 (20 copies/cell, a lower limit of
appreciable expression) (Figure 1B) (Kurimoto et al., 2006) corre-
sponded to the saddles of the bimodal distributions (Figure 3A).
We therefore defined the ‘‘enrichment levels’’ of H3K27me3
around the TSSs as the fold difference from the IP levels corre-
sponding to a log2 expression level of 8, so that the enrichment
levels were log-proportionally correlated with the expression
levels.
Accordingly, we identified the TSSs with significant changes
of the H3K27me3 enrichment levels (>2 fold) between the
successive stages and, consequently, the TSSs with the highest
H3K27me3 enrichment levels in ESCs (1,830, the ESC PRC2
targets), EpiLCs (1,732, the EpiLC PRC2 targets), d2 PGCLCs
(1,988, the d2 PGCLC PRC2 targets), or d6 PGCLCs (1,693,
the d6 PGCLC PRC2 targets) (Figure 3D). Accordingly, the
ESC PRC2 targets were enriched in genes for ‘‘gamete genera-
tion’’ and ‘‘spermatogenesis,’’ whereas the d2 and d6 PGCLC
PRC2 targets were enriched in genes for ‘‘neuron differentia-
tion,’’ ‘‘embryonic morphogenesis,’’ and ‘‘pattern specification
process’’ (Figure 3E and Figure S4C). Thus, key developmental
regulators are more strongly repressed by PRC2 in PGCLCs
than in ESCs and EpiLCs. The fact that the d2 PGCLC
genes were enriched with distinct developmental regulators
(Figures 1D and 1E) indicates that a subset of developmental
regulators are specifically activated, whereas the remaining
majority of developmental regulators are repressed by PRC2 in
d2 PGCLCs. Indeed, many developmental regulators did not(D) Changes in the H3K27me3 enrichment level around TSSs. The numbers of T
(gray) in each cell type compared to a neighboring cell type are indicated. The nu
are indicated in parentheses below each cell type.
(E) Enrichment of the indicated GO terms in the PRC2 targets of the four cell typ
(F) Heat map representation of the PRC2 targets of the four cell types and their e
(G) Classification of the PRC2 targets of the four cell types by promoter classes.
(H) Comparison of the H3K27me3 IP levels around TSSs between d2 PGCLC
corresponding colors) and unchanged (gray) in each cell type are indicated. Ge
gene expression classes (d2 and d6 PGCLC genes are enriched).
See also Figures S2, S4, and S6.show significant expression during in vitro PGC specification
and exhibited particularly high H3K27me3 enrichment levels in
d2 and d6 PGCLCs (Figure 3F). The four PRC2 target classes
show expression in distinct cell types and there is no apparent
link between the timings of the genes acquiring robust PRC2-
based repressive states and the activation of their expression
(Figure 3F).
The ESC and d6 PGCLC PRC2 targets consisted of 40% to
50% HCPs, 20% ICPs, and 30% LCPs, whereas the EpiLC
PRC2 targets showed depletion of HCPs (20%) and enrich-
ment with LCPs (55%), and the d2 PGCLC PRC2 targets
were highly enriched with HCPs (80%) (Figure 3G). This
suggests that during the ESC-to-EpiLC transition, many devel-
opmental regulators with HCPs reduce their H3K27me3 levels
for differentiation toward three germ layers, whereas during
the EpiLC-to-d2 PGCLC transition, only specific developmental
regulators, in response to BMP4, are activated, while those for
unrelated lineages are strongly repressed by PRC2.
To examine the impact of BMP4 signaling on H3K27me3
acquisition, we compared the H3K27me3 states between
d2 PGCLCs and the EpiLC aggregates stimulated only by LIF
(leukemia inhibitory factor) for two days (d2 LIF Ag). Many
developmental regulators and PGC genes upregulated in d2
PGCLCs acquired a high level of H3K27me3 in d2 LIF Ag,
indicating that BMP4 signaling prevents the acquisition of or
depletes H3K27me3 from these genes (Figure 3H and Figures
S4D and S4E).
Transitions in Bivalency
Bivalent promoters with both activating H3K4me3 and repres-
sing H3K27me3 are prevalent in developmental regulators and
may represent a poised state for a timely activation of associated
genes (Voigt et al., 2013). The bivalency may be key for the germ
cell lineage to activate developmental genes at an appropriate
time point after fertilization (Sachs et al., 2013). However, how
the germ cell lineage may acquire the bivalency has been
unknown. We therefore looked at the transitions in bivalency
during in vitro PGC specification.
We defined the bivalent genes as those that show no/low
expression (log2 expression levels <8) and bear substantial
levels of both H3K27me3 and H3K4me3 (Figures 4A and 4B
and Figure S5A). Throughout in vitro PGC specification, a large
number of genes were classified as bivalent (1,798, 2,863,
1,559, and 2,435 genes for ESCs, EpiLCs, d2 PGCLCs, and
d6 PGCLCs, respectively), and such genes were most sig-
nificantly enriched with those for ‘‘neuron differentiation’’ (Fig-
ures 4C and 4D and Figure S5B). We verified by sequential
ChIP-qPCR that the 12 gene loci identified as bivalent in EpiLCsSSs upregulated (>2-fold, marked by corresponding colors) and unchanged
mbers of TSSs with the highest H3K27me3 enrichment levels in each cell type
es.
xpression.
s and d2 LIF Ag. The numbers of TSSs upregulated (>2-fold, marked by
nes that show higher H3K27me3 IP levels in d2 LIF Ag are classified by the
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Figure 4. Dynamics of Bivalency for In Vitro PGC Specification
(A) Definition of the bivalent state. The scatter plots show the log2 levels of the H3K4me3 peaks around the TSSs and those of the neighboring (<1 kb from the
centers of the H3K4me3 peaks) H3K27me3 (data for d6 PGCLCs). The modification levels corresponding to a log2 expression level of 8 are indicated by dotted
lines (see Supplemental Experimental Procedures). Bivalent genes (indicated by red dots) are defined as those bearing both H3K27me3 and H3K4me3 at levels
higher than those indicated by the dotted lines.
(B) Heat map representation of the H3K4me3 levels ±5 kb from the TSSs and the corresponding H3K27me3 levels. Dotted lines correspond to the genes with a
log2 expression level of 8.
(C) Classification of the bivalent genes (orange, with their numbers) by promoter classes. Only those genes that were expressed at levels lower than a log2
expression level of 8 were evaluated (see also Figure S5A). The genes that bear H3K4me3 only (blue), H3K27me3 only (green), or neither modification (pale) are
also shown, with their numbers.
(D) GO term enrichment in the bivalent genes in the four cell types.
(E) The change of the H3K4me3 and H3K27me3 states of the bivalent genes in the stage transitions. The numbers of the genes whose chromatin states are
changed from bivalency to the indicated states are shown.
(F) Fraction of the bivalent genes among the PRC2 targets in the four cell types.
(G) ChIP-seq track transition for H3K4me3 and H3K27me3 in the 20 kb region around Adora2a, which upregulates H3K4me3 and regains bivalency in d6
PGCLCs.
See also Figures S5 and S6.
524 Cell Stem Cell 16, 517–532, May 7, 2015 ª2015 Elsevier Inc.
indeed bear both H3K4me3 and H3K27me3 on the same loci
(Figure S5C).
A majority (1,297/1,798, 72%) of the bivalent genes in ESCs
remained bivalent during the ESC-to-EpiLC transition and a large
number (1,566) of genes were newly recruited as bivalent in this
transition (Figure 4E and Figure S5D); consequently, EpiLCs bore
the largest number of bivalent genes (Figure 4C). During the
EpiLC-to-d2 PGCLC transition, however, only 44% (1,252/
2,863) of the bivalent genes in EpiLCs remained bivalent
(307 genes became newly bivalent in d2 PGCLCs) and, remark-
ably, as many as 34% (985/2,863), which were highly enriched
with genes for ‘‘neuron differentiation’’ (p = 2.3 3 1024), only
became H3K27me3 only in d2 PGCLCs (Figure 4E and Fig-
ure S5D). Accordingly, among the d2 PGCLC PRC2 targets,
more than 50% were bivalent in EpiLCs, but less than 30%
were bivalent in d2 PGCLCs (Figure 4F), indicating that the d2
PGCLC PRC2 targets mainly reflect the bivalent genes in EpiLCs
and that, compared to EpiLCs, d2 PGCLCs lose their potential
for ‘‘neuron differentiation’’ and are restricted to an early meso-
dermal/PGC state.
In contrast, during the d2-to-d6 PGCLC transition, a majority
(1,123/1,559, 72%) of the bivalent genes in d2 PGCLCs re-
mained bivalent and a larger number (1,312) of genes were newly
recruited as bivalent (Figure 4E and Figure S5D). As a result,
40% of the d2 and d6 PGCLC PRC2 targets were bivalent in
d6 PGCLCs (Figure 4F), indicating that d6 PGCLCs re-acquire
a potentially developmentally more permissive state; i.e., d6
PGCLCs gain H3K4me3 around the TSSs of the genes repressed
by H3K27me3 (Figure 4G). Additionally, consistent with the
depletion of HCPs in the EpiLC PRC2 targets, only 10% of
the EpiLC PRC2 targets were bivalent throughout in vitro PGC
specification (Figures 3G and 4F). Thus, developmental regula-
tors with HCPs are in more permissive states with relatively
low H3K27me3 and high H3K4me3 in EpiLCs, acquire highly
repressive states in d2 PGCLCs, and regain potentially more
permissive states in d6 PGCLCs, although it is important to
note that d2 and d6 PGCLCs exhibit higher H3K27me3 enrich-
ment levels in developmental regulators.
We compared the bivalent genes in d6 PGCLCs with those
in E11.5 PGCs (Sachs et al., 2013). A majority of the bivalent
genes in d6 PGCLCs were in common with those in E11.5
PGCs (1,423/2,435) (Figure S5E). While the bivalent genes
specific to d6 PGCLCs (1,012/2,435) did not show enrichment
in GO terms for major developmental processes such as
‘‘neuron differentiation,’’ ‘‘pattern specification,’’ and ‘‘embry-
onic morphogenesis,’’ those specific to E11.5 PGCs showed
enrichment of all such terms (Figure S5E). Thus, d6 PGCLCs
are similar in bivalency to E11.5 PGCs and may acquire
more bivalency when cultured further under an appropriate
condition.
Genome-wide Reduction of H3K9me2
We next evaluated the transitions of H3K9me2 during in vitro
PGC specification. Strikingly, the H3K9me2 level was drastically
reduced throughout the genome and around the TSSs in d6
PGCLCs (Figures 5A–5D), reinforcing the observations made
by immunofluorescence and western blot analysis (Seki et al.,
2005). Throughout the in vitro PGC specification, the TSSs
associated with high-level H3K9me2 (IP level > 1) were pre-dominantly those of the LCP genes and were enriched with
genes for ‘‘inflammatory response’’ and ‘‘defense response’’
(Figure 5E), whereas a majority of the HCP and ICP genes
were essentially devoid of this modification (Figure 5B). The
H3K9me2 levels around the TSSs were highly anti-proportional
to the expression levels of the associated genes (Figure 5D
and Figure S4A).
Figure 5F illustrates ChIP-seq tracks for the H3K27me3 and
H3K9me2 transitions in a 50 Mb region on chromosome 11:
the H3K9me2 level was high in ESCs, EpiLCs, and d2 PGCLCs
and significantly downregulated in d6 PGCLCs. The H3K9me2
levels in d2 PGCLCs were distributed in a narrower range
compared to those of the other cell types (Figure 5B and Fig-
ure S4A), which may signify a unique property of d2 PGCLCs
(i.e., transient acquisition of a somatic program) during in vitro
PGC specification. In ESCs, EpiLCs, and d2 PGCLCs,
H3K9me2 was enriched in lamina-associated domains (LADs),
the genome regions that are associated with the nuclear lamina
(NL) and are long interspersed nuclear element (LINE)-rich and
gene-poor, and typically harbor low or no gene-expression levels
(Figure 5F) (Guelen et al., 2008; Peric-Hupkes et al., 2010).
Remarkably, d6 PGCLCs showed a reduction of H3K9me2 in
LADs as well (Figures 5F and 5G).
We found that the expression of Lamin A is progressively
decreased, while expression of Lamin B1 and B2 remain rela-
tively constant during in vitro PGC specification (Figure 5H).
The immunofluorescence analysis, however, revealed that,
compared to EpiLCs, d6 PGCLCs showed a reduced level of
LAMIN B1 and appeared to have a diminished level of DAPI-
dense heterochromatin around the nuclearmembrane (Figure 5I).
However, similar to ESCs and EpiLCs, d6 PGCLCs exhibited a
relative depletion of H3K27me3 in LADs (Figure 5G). d6 PGCLCs
may thus bear a chromosome structure relatively free from
constraints imposed by LAD-NL interactions, although they
may still retain some features distinguishing LADs from other
parts of the genome.
Repression of ‘‘Germline Genes’’ by H3K27me3
and H3K9me2
Upon colonization of embryonic gonads, PGCs upregulate a set
of genes, often referred to as ‘‘germline genes,’’ that are crucial
for their progression into meiosis in females and for transposon
repression in males. It has been proposed/reported that these
genes are activated by the genome-wide DNA demethylation
in PGCs (Hackett et al., 2012; Maatouk et al., 2006) and lack
histone modifications in somatic cells (Hackett et al., 2012). It
is unknown how they are regulated by histone modifications in
early PGCs. We therefore explored their histone modifications
during in vitro PGC specification, when a majority of them were
in a repressed state (Figure 6A).
The key germline genes, Ddx4 and Dazl, lacked H3K4me3
and H3K27ac throughout the in vitro PGC specification, despite
the fact that they showed low-level expression in d6 PGCLCs
(Figures 6A and 6B). Remarkably, a majority of the germline
genes harbored a high level of H3K27me3 throughout the
in vitro PGC specification (Figures 6B and 6C). Because they
essentially lacked H3K4me3, less than 10% of them showed
bivalency (Figure S5F). Interestingly, they were marked by an
exceptionally high level of H3K9me2 in ESCs and EpiLCs, andCell Stem Cell 16, 517–532, May 7, 2015 ª2015 Elsevier Inc. 525
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Figure 5. Dynamics of H3K9me2 for In Vitro
PGC Specification
(A) ChIP-qPCR (with SDs, two biological replicates)
for H3K9me2 in the indicated repeat elements.
(B) The log2 H3K9me2 IP level-frequency plots for
the genome and the HCP, ICP, and LCP genes.
(C) The H3K9me2 IP levels in repeat elements in
the four cell types.
(D) The relationship between the log2 expression
levels of genes (color codes indicated) and the
H3K9me2 levels around them (±50 kb from their
TSSs and TTSs [transcription termination sites])
in the four cell types.
(E) GO term enrichment in genes with high
H3K9me2 levels (IP level > 1) in ESCs.
(F) ChIP-seq track transitions for H3K27me3 (top,
blue) and H3K9me2 (bottom, red) IP levels in a 50
Mb region on chromosome 11. The lamina-asso-
ciated domains (LADs) (Peric-Hupkes et al., 2010)
are indicated by red bold lines at the bottom.
(G) H3K9me2 and H3K27me3 distributions around
LADs (±50 kb) in the four cell types (color codes
indicated).
(H) Expression of Lmna, Lmnb1/b2, and Lbr (SDs,
two biological replicates).
(I) Immunofluorescence analysis of heterochro-
matin structure identified by DAPI staining (white)
and LAMIN B1 expression (blue) in d6 PGCLCs
(BV-positive cells, yellow, indicated by yellow
arrows) and EpiLCs (BV-negative cells, indicated
by blue arrows). Bar, 10 mm.
See also Figure S2.they continued to show such a trend in d6 PGCLCs with a very
low level of genome-wide H3K9me2 (Figures 6B and 6D).
We analyzed the published data on expression of H3K27me3
and its distribution in the germline genes in PGCs at E11.5 (Kagi-
wada et al., 2013; Sachs et al., 2013). Many germline genes were
expressed in PGCs at E11.5 (Figure 6E), and in general, there
was a negative correlation between the expression and the
H3K27me3 levels of the germline genes, although some germline
genes expressed at this stage still exhibited relatively high levels
of H3K27me3 (Figures 6F and 6G). Thus, we propose that, unlike
in somatic cells, the germline genes are repressed by both
H3K27me3 and H3K9me2 during PGC/PGCLC specification
and development.526 Cell Stem Cell 16, 517–532, May 7, 2015 ª2015 Elsevier Inc.EpiLCs versus EpiSCs
Having established the chromatin-state
dynamics during in vitro PGC specifica-
tion, we compared the chromatin states
between EpiLCs and epiblast stem cells
(EpiSCs) (Factor et al., 2014), which bear
robust and little, if any, competence for
the germ cell fate, respectively (Hayashi
et al., 2011).
Genes bearing higher H3K27ac peaks
in EpiSCs than in EpiLCs were enriched
in the GO term for ‘‘regulation of tran-
scription, DNA-dependent,’’ including
characteristic TFs (Figure S6A), indicating
that EpiSCs bear distinct transcriptionalcircuitry with unique epigenetic foundations. EpiSCs, but not
EpiLCs, expressed genes associated with pattern specifi-
cation/tissue morphogenesis such as Hoxa1, Hoxb1-b3,
Snai1, Id3, and Fgf8, albeit at low levels, showing substantial
H3K4me3 and H3K27ac peaks around such genes (Figure S6B).
In good agreement with these findings, genes bearing higher
H3K27ac peaks in EpiSCs than in EpiLCs included higher
numbers of genes for ‘‘neuron differentiation,’’ ‘‘embryonic
development,’’ and ‘‘pattern specification’’ than genes bearing
higher H3K27ac peaks in EpiLCs than in EpiSCs (Figure S6C).
Moreover, we found that the bivalent genes specific to EpiSCs,
but not EpiLCs, were enriched with those for ‘‘pattern specifi-
cation’’ and ‘‘embryonic morphogenesis’’ (Figure S6D). Thus,
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Figure 6. Regulation of Germline Genes for In Vitro PGC Specification
(A) Expression of the indicated germline genes (SDs, two biological replicates).
(B) ChIP-seq track transitions for H3K4me3, H3K27ac, H3K27me3, and H3K9me2 ±5 kb from the TSSs (dotted lines) of Ddx4, Dazl, and Prdm14.
(C and D) The log2 H3K27me3 (C) or H3K9me2 (D) IP level-frequency plots for germline genes (102 genes). Representative germline genes are indicated, and
those expressed at more than a log2 expression level of 8 are colored in red. Pale red lines represent the plots for all genes as a reference.
(E) Expression of the indicated germline genes in PGCs from E9.5 to E13.5 (F, female; M, male) (SDs, two biological replicates) (Kagiwada et al., 2013).
(F) The log2 H3K27me3 level-frequency plots for germline and all genes in PGCs at E11.5 (Sachs et al., 2013) as in (C). The H3K27me3 level forHoxb1 is indicated
by a triangle.
(G) The log2 H3K27me3 level-log2 expression level plots for germline (red dots) and all (gray dots) genes in PGCs at E11.5 (Kagiwada et al., 2013; Sachs et al.,
2013). Dotted lines indicate a log2 expression level of 8 and the log2 H3K27me3 level corresponding to a log2 expression level of 8.
See also Figure S6.EpiSCs bear an epigenetic property representing a more primed
state for somatic differentiation than EpiLCs. Interestingly, the
germline genes exhibited much higher H3K27me3 in EpiLCs
than in EpiSCs, indicating that they are properly repressed in
EpiLCs for appropriate later expression (Figure S6E). Thus,
EpiLCs and EpiSCs bear different epigenetic properties reflect-
ing their transcriptional and functional differences.Distribution of BLIMP1 and T
We determined the binding sites of BLIMP1 and T, two key tran-
scriptional regulators for PGC specification (Aramaki et al., 2013;
Ohinata et al., 2005), and explored their relationship with the
chromatin states during in vitro PGC specification. Figures 7A
and 7B provide examples of the BLIMP1-binding peaks in the
Klf9 and Hoxa loci and the T-binding peak in the Prdm1 locus,Cell Stem Cell 16, 517–532, May 7, 2015 ª2015 Elsevier Inc. 527
403
(466)
5693
4963
40
(48)986
165
(196)
(2308)
EGFP-BLIMP1,
d6PGCLC
EGFP-BLIMP1,
d2PGCLC
BLIMP1,
Magnúsdóttir
et al.
G
C
A B
D E F
BLIMP1(top50%) H3K27me3 H3K27acT(top50%)
E
S
C
E
pi
LC
d2
 P
G
C
LC
d2
 P
G
C
LC
d6
 P
G
C
LC
E
S
C
E
pi
LC
d2
 P
G
C
LC
d6
 P
G
C
LC
E
pi
LC
+B
M
P
4
0 0 0 55 2
±50Kb
BLIMP1 peaks
16 64 256
N
um
be
r o
f p
ea
ks
0
500
1000
1500
2000
2500
3000
3500
at d2 (d2&d6 peaks)
at d6 (d2&d6 peaks)
at d2 (d2 only peaks)
at d6 (d6 only peaks)
T
En
ric
hm
en
t s
co
re
BLIMP1 targets (d2 PGCLC)
Core enrichment (630)
0.1
0.0
-0.1
-0.2
-0.3
P<0.001
H
ox
a1
G
ja
1
M
yc
U
hr
f1
D
nm
t3
b
B
m
i1
W
nt
5bK
lf9
Fg
f4
Tb
x3
S
rc
C
dx
1
K
rt8
K
rt1
8
W
nt
3
E
hm
t1
H
ox
b5
H
ox
c5
Td
gf
1
H
ox
a2
A
cv
r1
c
Tg
if1
E
rb
b2
D
nm
t3
a
Rank of loss-of-function
eﬀect on expression
200 Kb
ESC
EpiLC
d2 PGCLC
d6 PGCLC
d2 PGCLC
d6 PGCLC
H
3K
27
m
e3
E
G
FP
-B
LI
M
P
1
Klf9
Core enrichment  (578)
En
ric
hm
en
t s
co
re 0.1
0.0
-0.1
-0.2
P<0.001
Td
fg
1
S
p8
M
yc
W
nt
5b
D
nm
t3
a
O
tx
2
H
ox
b5
Fg
f4
Fg
f5
Le
fty
1
H
ox
a2
K
rt8
K
lf4T
W
nt
3
U
tf1
H
ox
a1
Tg
fb
r3
K
rt1
8
P
rp
s1
G
li3
E
rb
b2S
rc
K
lf9
Rank of gain-of-function
eﬀect on expression
Peak Intensity(IP/Input)
B
LI
M
P
1 
 
P<0.001
En
ric
hm
en
t s
co
re
0.0
0.1
0.2
0.3
0.4
H
ox
a1
H
ox
a5
A
sc
l1
V
eg
fc
N
um
b
D
lg
5
A
vp
r1
b
G
at
a6
C
cn
g2
Tb
x6
Lr
p1
Fg
f8
B
m
pe
r
M
es
p1
A
nx
a3
Tb
x3
K
rt8
G
jb
3
M
sg
n1
D
us
p5
H
ox
a2
T targets
Rank of Expr.  diﬀ.
(d2PGCLC and EpiLC)
Core enrichment (202)
H
ox
a4
ESC
EpiLC
d2PGCLC
d6PGCLC
EpiLC
+BMP4
36hr
H
3K
27
ac
T
Prdm1
200 Kb200 Kb
a1 a13Hoxa cluster
H
I
T BLIMP1
GO: Embryonic morphogenesis,
Pattern specification process
Hoxa1,
Tbx3,
Grsf1, 
Ext1
Fgf8, Mesp1,
Mesp2, Hoxa4,
Hoxa5, Vegfc,
Tbx6, Msgn1, ...
Hoxb5, Hoxc5, Hoxc6,
Hoxc10,Cdx1,Otx1,Otx2, 
Acvr1c, Tgif1, Fgf4,
Tdgf1, Wnt3, Gja1, ... 
ESC EpiLC
d6
PGCLC
d2
PGCLC
PGC specification
Somatic development (earlier)
Epiblast
ESC
Somatic development (later)
Germline (later)
Genes for:
H3K27me3
H3K9me2
H3K27me3
at TSS
G
en
om
e-
w
id
e
Expression
Activin, bFGF
Aggregation
G9A/GLP
BLIMP1
Prdm1, Prm14, Kit, Dnd1, 
Itgb3, stella, Uhrf2, ...
T, Hoxa1,Tbx3, 
Gja1,Tdgf1, tgif1...
Fgf5, Myc, Dnmt3a, 
Dmt3b
Uhrf1, Fgf4, Cdh1, 
Src, Sall1, ...
Hoxa3, Hoxb4, Hoxc5, 
Hoxc9, Hoxc10, Otx1, 
Cdx4,... 
Mael, Tdrd12, 
Piwil2,Piwil4,Tdrd7, 
Tdrd9, Spo11, ...
T
Enhancer
BMP4
0.5 0.75
26
30
30
30
30
0.75
0.75
0.75
0.5
0.5
0.5
12 4
412
0
0.1
0.2
0.3
0.4
0.5
BLIMP1, d2PGCLC (top50%)
H3K27me3
-50Kb 0 50Kb
In
te
ns
ity
1
2
3
4
5
0
H3K27ac
T, EpiLC+BMP4 36hr (top50%)
ESC
EpiLC
d2 PGCLC
d6 PGCLC
-50Kb 0 50Kb
Figure 7. Distribution of BLIMP1 and T for In Vitro PGC Specification
(A) ChIP-seq track transitions for H3K27me3 binding (top, blue) and BLIMP1 binding (bottom, red) in the 200 kb regions around Klf9 (left) and the Hoxa cluster
(right).
(B) ChIP-seq track transitions for H3K27ac-binding (top, red) and T-binding (bottom, blue) in the 200 kb region around Prdm1. The genome-wide binding profiles
of T were determined in floating aggregates of EpiLCs stimulated by BMP4 and LIF for 36 hr (Aramaki et al., 2013). In (A) and (B), the dotted lines indicate the TSSs
of the genes bound by the TFs.
(legend continued on next page)
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respectively (see also Figure S7A). We identified 7,122 and
11,224 EGFP-BLIMP1 binding peaks in d2 and d6 PGCLCs,
respectively, which were highly overlapped with each other (Fig-
ures 7C and 7D), but were only partially overlapped with those
identified in P19 cells overexpressing Blimp1 (Figure 7C) (Mag-
nu´sdo´ttir et al., 2013), indicating that the cellular context plays
a key role in the distribution and function of TFs (Nakaki et al.,
2013). Both BLIMP1- and T-binding sites were enriched around
TSSs (Figure S7B) and were distributed in different promoter
classes in a proportional manner (Figure S7C). The motifs for
BLIMP1 and T binding showed partial, but not perfect, overlaps
with previously identifiedmotifs, extending their potential targets
(Figures S7D–S7G).
We explored the relationship between the genes bound by
BLIMP1 and (1) the genes upregulated or downregulated in
Blimp1-knockout cells (Kurimoto et al., 2008) and (2) the genes
upregulated or downregulated in EpiLCs overexpressing Blimp1
(Nakaki et al., 2013) by gene set enrichment analysis (GSEA).
Both the genes upregulated in Blimp1-knockout cells and those
downregulated in EpiLCs overexpressing Blimp1 were enriched
with those bound by BLIMP1, revealing 630 and 578 targets for
BLIMP1 repression, respectively (Figure 7E and Figure S7H).
However, it should be noted that BLIMP1 binds to a much higher
number of genes than it appears to regulate at an appreciable
level (Figure 7E). We also found by GSEA that T preferentially tar-
gets at least 202 genes upregulated in d2 PGCLCs (Figure 7F
and Figure S7H).
The targets of BLIMP1 in d2 PGCLCs showed only a small
overlap with those of T (Figure S7I): while both BLIMP1 and
T targets were enriched in genes for embryonic development/
pattern specification processes, targets of T as an activator
were skewed to genes involved in early mesoderm formation
and those of BLIMP1 as a repressor were for more various
biological processes (Figures S7J and S7K). Remarkably, the
BLIMP1-binding sites in d2 PGCLCs, which were mostly pre-
served in d6 PGCLCs, exhibited an enrichment of H3K27me3
in d6, but not d2, PGCLCs (Figures 7G and 7H), suggesting
that BLIMP1 functions as a nucleator for PRC2 recruitment
and spreading for a stable repression of gene expression.
In contrast, the T-binding sites were enriched with H3K27ac
(Figures 7G and 7H), consistent with the notion that T activates
transcription by recruiting histone acetyltransferase in a
sequence-dependent fashion.(C) Venn diagrams showing the overlap of BLIMP1 peaks in d2 and d6 PGCLCs
(D) The number of BLIMP1 peaks plotted against the intensity of BLIMP1 peaks
(E) Gene set enrichment analysis (GSEA) of BLIMP-bound genes and gene expr
gulated genes on the right) and gain of function (Nakaki et al., 2013) (right; downre
genes determined by both loss- and gain-of-function effects of Blimp1.
(F) GSEA of T-bound genes and gene expression difference between EpiLCs and d
were ordered according to the rank of the difference of expression levels.
(G) (Left) Heat map representation of BLIMP1 peaks in d2 PGCLCs (top 50%), wh
PGCLCs. (Right) Heat map representation of T peaks in EpiLC aggregates stimula
around the TSSs) in d2, but not d6, PGCLCs.
(H) (Left) Averaged intensity plots for H3K27me3 levels in the four cell types around
intensity plot for H3K27ac levels in the four cell types around ±50 kb of the top 5
codes for the cell types are indicated on the right.
(I) (Top) A model for transcription and chromatin-state dynamics during in vitro
morphogenesis’’ and ‘‘pattern specification’’ by BLIMP1 (repression) and T (activ
See also Figures S1 and S7and Table S6.DISCUSSION
We have established the concept of epigenetic reprogramming
upon PGC specification by a comprehensive analysis of tran-
scription and chromatin-state dynamics during in vitro PGC
specification (Figure 7I). We showed that the H3K27me3 IP
levels, including those around the TSSs, exhibited dynamic
global changes with negative correlations with gene expression
levels in all cell types (Figure 3A and Figure S4A), suggesting that
the absolute levels of H3K27me3 around the TSSs in a certain
cell type may not necessarily be indicative of the expression
levels of the associated genes. This is consistent with the
observations that ESCs lacking PRC2 activity appear to pro-
liferate in a normal fashion, although their differentiation poten-
tials are severely perturbed (Margueron and Reinberg, 2011).
The significance of the genome-wide deposition of high
H3K27me3 in ESCs therefore remains unclear. The high
H3K27me3 levels may reflect gene expression circuitry for
(potentially) pluripotent cells, since d6 PGCLCs, which regain
the relevant genes (Figures 1D and 1E and Figure S1A), also
exhibit high H3K27me3 throughout the genome (Figure 3A and
Figure S4A). Accordingly, there appears to be a tendency for
the PRC2 components to be expressed at higher levels in
both ESCs and d6 PGCLCs (Figure S4F). BLIMP1 as a potential
nucleator for H3K27me3 deposition and spreading (Figures 7A,
7G, and 7H and Figure S7A) may also contribute to the high
H3K27me3 level in d6 PGCLCs.
Coupled with the dynamic regulation of H3K27me3, genes
bearing bivalent promoters exhibit dynamic changes during
in vitro PGC specification (Figure 4). Notably, EpiLCs bear the
highest number of bivalent genes with the highest enrichment
for developmental regulators, and at the same time, they show
the narrowest range of the H3K27me3 IP level among the four
cell types (Figure 3A and Figure 4), suggesting that EpiLCs
acquire an epigenome in which a wide range of developmental
regulators are repressed by relatively low levels of H3K27me3
and bear low levels of H3K4me3, which may represent a bona
fide primed state immediately ready for differentiation into cells
of the three germ layers. In good agreement with this idea,
EpiLCs do not overtly upregulate genes for developmental regu-
lators (Figures 1D and 1E), and EpiLCs, but not ESCs, respond
quickly to BMP4 to deplete or prevent the acquisition of
H3K27me3 from genes for early mesoderm induction/PGCand those reported previously (Magnu´sdo´ttir et al., 2013).
in d2 and d6 PGCLCs (color codes as indicated).
ession difference caused by loss of function (Kurimoto et al., 2008) (left; upre-
gulated genes on the right) of Blimp1. Genes marked in red are core enrichment
2 PGCLCs (genes upregulated in d2 PGCLC on the left). In (E) and (F), all genes
ich show enrichment of H3K27me3 (±50 kb around the TSSs) in d6, but not d2,
ted by BMP4 (Aramaki et al., 2013), which show enrichment in H3K27ac (±50 kb
±50 kb of the top 50%BLIMP1-binding peaks in d2 PGCLCs. (Right) Averaged
0% T-binding peaks in EpiLC aggregates stimulated by BMP4 for 36 hr. Color
PGC specification. (Bottom) Differential regulation of genes for ‘‘embryonic
ation).
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specification to be induced as PGCLCs (Figure 3H) (Hayashi
et al., 2011): d2 PGCLCs instead deplete H3K4me3 from, and
deposit high H3K27me3 onto, a large number of developmental
regulators for unrelated lineages for their repression (Figures 3
and 4). Additionally, compared to ESCs, EpiLCs acquire a
distinct enhancer pattern (Figure 2) (Buecker et al., 2014), which
would also contribute to their developmental potential. It will be
important to explore whether pre-gastrulating epiblasts bear an
epigenomic equivalent to EpiLCs.
d6 PGCLCs upregulate the global H3K27me3 levels (Figure 3)
and newly recruit a large number of genes, many of which are
marked only by H3K27me3 in d2 PGCLCs, as bivalent genes
(Figure 4 and Figure S5D). This indicates that d6 PGCLCs intro-
duce H3K4me3 onto many genes at levels that maintain their
H3K27me3-based repression. Accordingly, d6 PGCLCs upregu-
lated a gene encoding an H3K4methyltransferase (MTase) (Mll3)
(Figure S4G). The mechanism by which d6 PGCLCs restore the
bivalency and the functional significance of bivalency in PGCs/
PGCLCs warrants further investigation.
Our results demonstrated a striking reduction of the
H3K9me2 levels in d6 PGCLCs (Figure 5). Repression of the
H3K9 MTases G9A and GLP in PGCs/PGCLCs may contribute
to the creation of this unique state (Seki et al., 2007), a possibility
that requires experimental validation. What, then, would be the
potential consequences of the genome-wide reduction of
H3K9me2 in PGCs/PGCLCs? We showed that d6 PGCLCs
bear altered nuclear architecture with diminution of DAPI-dense
heterochromatin and reduced concentration of LAMIN B1
around the nuclear periphery (Figure 5I). This unique nuclear
architecture of d6 PGCLCs is reminiscent of that of PGCs
(Kagiwada et al., 2013) and may be a key of epigenetic reprog-
ramming in PGCs/PGCLCs. Considering the reported link be-
tween the loss of H3K9me2 and DNA demethylation (Tachibana
et al., 2008), another potential result would be that PGCs un-
dergo genome-wide DNA demethylation (Seisenberger et al.,
2012). Indeed, compared to EpiLCs, PGCLCs show substantial
genome-wide DNA demethylation (K. Shirane, K.K., M.S., and
H. Sasaki, data not shown). Further studies will be necessary
to explore these possibilities.
A recent study showed that the germline genes lack any
repressive histone modifications and are repressed solely by
DNA methylation in somatic cells (Hackett et al., 2012). We
showed that the germline genes are enriched in ESC PRC2
targets and a majority of them bear high H3K27me3 and
H3K9me2 levels throughout in vitro PGC specification (Figure 6
and Figure S4C). These findings suggest that the germline genes
are repressed by both DNA methylation and histone modifica-
tions in PGCs. In good agreement with this idea, many of the
germline genes expressed in PGCs at E11.5 are depleted of
H3K27me3 from their promoters at the same stage (Figures
6E–6G) (Sachs et al., 2013), and the germline genes are upregu-
lated prematurely in PGCs with impaired PRC1 activity (Yoko-
bayashi et al., 2013). The comprehensive profiling of transcrip-
tion and chromatin-state transitions for the in vitro PGC
specification pathway provided herein should serve as a robust
foundation not only for reconstituting the regulatory networks
underlying epigenetic reprogramming in PGCs, but also for
developing culture conditions for the induction of PGCLCs into
a more mature phenotype.530 Cell Stem Cell 16, 517–532, May 7, 2015 ª2015 Elsevier Inc.EXPERIMENTAL PROCEDURES
The experimental procedures for analysis of the gene expression for in vitro
PGC specification, generation of EGFP-Blimp1 knockin mice and ESCs,
induction from ESCs of EpiLCs and PGCLCs, normalization of the ChIP-seq
data, ChIP-seq data analysis, sequential ChIP-qPCR, comparison of the
ChIP-seq data for EpiLCs with those for EpiSCs, GSEA, immunofluorescence
analysis of spread cells, immunofluorescence analysis of cryosections, histol-
ogy, and western blot analysis are available in the Supplemental Information.
ChIP
BVSC and EGFP-Blimp1 knockin cells were used for ChIP of histone H3/his-
tone H3 modifications (H3K4me3, H3K9me2, H3K27ac, and H3K27me3) and
EGFP-BLIMP1 respectively. Mouse monoclonal antibodies were used for
ChIP-seq/ChIP-qPCR for histone H3 modifications (Hayashi-Takanaka et al.,
2011), and rabbit polyclonal antibodies were used for histone H3 and EGFP-
BLIMP1 (Table S2 and Table S3).
Prior to IP, themouse antibodies and the rabbit antibodies were reactedwith
20 ml of M280Dynabeads Sheep anti-mouse IgG and 10 ml ofM280Dynabeads
Protein G (Life Technologies), respectively.
ChIP was performed as described previously (Luo et al., 1998) with modifi-
cation. Cells were suspended in 1 ml of PBS and fixed by the addition of 27 ml
of 36.5% formalin (Sigma) for 10 min at room temperature. Fixation was termi-
nated by the addition of 110 ml of 1.5M glycine. The fixed cells were washed
twice in PBS containing 0.1% BSA and were lysed in 400 ml SDS-lysis buffer
(50 mM Tris-HCl [pH 8.0] containing 1% SDS, 10 mM EDTA, and 1 mM
PMSF) on ice for 10 min. Chromatins were then solubilized using a Bioruptor
UCD250 with ice-chilled water, with 10 cycles of 30 s sonication at high power
and 60 s intervals. The sonication products were centrifuged at 16,0003 g for
5min. The supernatants were diluted in 1ml ChIP dilution buffer (16.7 mMTris-
HCl [pH 8.0], 0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 167 mM NaCl,
1 mM PMSF, 2 mg/ml tRNA [Roche]) and were divided into 0.1 ml as input
DNA and 1.3 ml as ChIP samples.
The ChIP samples were mixed with the Dynabeads-antibody complexes
and rotated at 4C overnight. The ChIP-ed Dynabeads were recovered using
a DynaMag-2 magnet (Life Technologies) and washed with 200 ml of low salt
buffer (20 mM Tris-Cl [pH 8.0] containing 0.1% SDS, 1% Triton X-100, 2 mM
EDTA, and 150 mMNaCl), a high salt buffer (20 mM Tris-Cl [pH 8.0] containing
0.1% SDS, 1% Triton X-100, 2 mM EDTA, and 500 mM NaCl), RIPA buffer
(10 mM Tris-Cl [pH 8.0] containing 1% sodium deoxycholate, 1% NP40,
250 mM LiCl, and 1 mM EDTA), and TE buffer (10 mM Tris-Cl [pH 8.0] contain-
ing 1 mM EDTA). The ChIP-ed Dynabeads were then incubated in new tubes
containing 50 ml of elution buffer (0.1 M NaHCO3, 1% SDS, 10 mM DTT, and
60 ng/ml tRNA) for 15 min at room temperature. The supernatants were
collected using DynaMag-2, and they were reverse-crosslinked by the addi-
tion of 8 ml of 2.5 M NaCl and being incubated at 65C overnight. Then, 2 ml
of 0.5 M EDTA, 4 ml of 1M Tris-Cl (pH 6.5), and 0.2 ml of 20 mg/ml proteinase
K solution were added to the reaction mixture, which was further incubated
at 45C for 1 hr. The ChIP-ed DNAs were then purified with Qiaquick PCR
purification columns, using the buffer EB supplemented with 4 ng/ml tRNA
(QIAGEN).
Library Preparation for Sequencing
The ChIP-ed and input DNAs were sheared to an average size of about 150 bp
by ultra-sonication (Covaris). The ChIP-ed DNAs obtained from 1 3 106 cells
were then subjected to the procedures for SOLiD Fragment Library Prepara-
tion (Life Technologies) according to the manufacturer’s instructions, except
for the ligation reaction, which was performed overnight.
For histone H3 and its modifications, ChIP-ed DNAs from 13 105 cells were
subjected to the procedures for SOLiD Fragment Library Preparation with a
modification, in which the size fractionation step using AMPure XP beads
(Agencourt) was omitted and a ligation reaction was performed overnight.
We developed a new method to prepare and precisely amplify libraries of
ChIP-ed DNA from a small number of cells, and we applied this method to
H3K4me3 from 1 3 105 cells and TFs from 3 3 105 1 3 106 cells. We pre-
pared the modified adaptor for the SOLiD library by annealing 50 mM each of
P1-T Adaptor/F and Barcode-Internal+12-mer/R (Table S1) in 13 Linker buffer
(50 mM Tris-HCl [pH 8.0] containing 100 mM NaCl and 1 mM EDTA) with a
step-wise cooling procedure (95C, 70C, 50C, 40C, and 25C for 15 min
each). We end-repaired the sheared DNAs by using an End-It DNA End-Repair
Kit (Epicenter) on a 120 ml scale according to the manufacturer’s instructions,
and we purified them by using a MinElute PCR purification kit (QIAGEN) with
540 ml of binding buffer PB3 (5.6 MGu HCl, 33.3% isopropanol) supplemented
with 10 ng/ml tRNA and 10 ml of elution buffer EB (QIAGEN) with 4 ng/ml tRNA.
The end-repaired DNAs were incubated in 20 ml of dA tailing mixture (0.2 mM
dATP [GEHealthcare], 13High Yield buffer [Greiner], 4 ng/ml tRNA, 2.5 units of
Taq DNA polymerase [Greiner]) for 10 min at 70C, and we purified them by
using a MinElute PCR purification kit with the buffers PB (QIAGEN) and EB
(11 ml) supplemented with tRNA. The dA-tailed DNAs were incubated in 15 ml
ligation mixture (1 3 DNA Ligase Reaction Buffer [Life Technologies], 0.1 mM
of the modified adaptor for the SOLiD library, and 2.5 units of ExpressLink
T4DNA Ligase [Life Technologies]) at 16C formore than 22 hr, andwe purified
them using a MinElute PCR purification kit with the buffers PB and EB (20 ml)
supplemented with tRNA. We then amplified the adaptor-ligated DNAs by us-
ing the Platinum Taq DNA Polymerase on a 50 ml reaction scale (Life Technol-
ogies) with 1 mM each of Library PCR primer 1 (Life Technologies) and Library
PCR primer Barcode001+Internal adaptor (Table S1). We purified the PCR
products by using 60 ml AMPure XP beads supplemented with 3.33 ml of
25%PEG8000 and 13.7 ml of 2.5MNaCl, and they were eluted in 30 ml of buffer
EB supplemented with tRNA. We then subjected the PCR products to another
PCR by using 1 mM each of Library PCR Primer 1 and P2-Barcode-N-Internal
primer (Table S1), and we purified them twice with AMPure XP beads supple-
mented with PEG8000 and NaCl. The barcode-tagged library DNAs were
sequenced on a SOLiD 5500xl platform (Life Technologies) to generate sin-
gle-end 50 bp reads. The experimental outlines, including PCR cycle numbers,
and mapping statistics are summarized in Table S3.
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